DrCastermansA
ActiveSummary
DrCastermansA has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €5,000 and a net result of €142,120. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 6% of 20,511 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
26-05
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Highest result from 2022 to 2025net €142,120 ▲23%
Operating result €184,603, net result €142,120, both a record.
03-06
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Liquidity more than 8 timescurrent ratio 53.15
Current ratio from 6.00 to 53.15; short-term debt falls from €16,630 to €3,787.
31-12
Financial
Equity above €200,000equity €202,589 ▲130%
A profit in every financial year since 2022 builds equity to €202,589.
04-10
Gazette deed
Registered officeRegistered-office move · Director in office3 facts ▸
Gazette deed
Registered office
Registered-office move · Director in office3 facts ▸
- Registered-office move, Langelostraat 169, 3360 Bierbeek
- Director in office, Julien Vancaster (director)
- Director in office, Anne Castermans (director)
07-06
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
07-06
NBB filing
Annual accounts filed
financial year 2022 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 2 deeds read
About the unread acts
Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.